OneChain Immunotherapeutics

Barcelona, Catalonia, Spain

https://www.onechaintx.com

Company profile

OneChain Immunotherapeutics company profile

OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.

Business identity

Website: https://www.onechaintx.com
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $0-$1M
Founded: 2020-01-01, Year

LinkedIn X

Headquarters

Headquarters: Barcelona, Catalonia, Spain
Country code: ES
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Seed
Funding rounds: 2
Total equity funding: $10.9M
Last funding: Seed / $7.3M / 2023-06-22
Last equity funding: Seed / $7.3M
Investors: 6
Lead investors: 1
Founders: 1
Articles: 12

Categories and groups

Biotechnology Life Science Biotechnology Science and Engineering

Founders and investors

Founders

Pablo Menéndez

Lead investors

Invivo Capital Partners

Investors

Centre for the Development of Industrial Technology (CDTI)Clave CapitalInvivo Capital PartnersJosep Carreras Leukaemia Research InstituteNara Capital